United States

TBG Diagnostics Ltd (PGLA.PK)

PGLA.PK on OTC Markets Group

Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

TBG Diagnostics says HY revenue from ordinary activities $1.8 mln
Monday, 28 Aug 2017 01:32am EDT 

Aug 28 (Reuters) - Tbg Diagnostics Ltd :HY revenue from ordinary activities up 30.3 percent to $1.8 million.HY net loss for the period $995,954 versus loss of $2.6 million.  Full Article

TBG Diagnostics enters into licensing agreement with National Taiwan University Hospital
Sunday, 12 Mar 2017 07:29pm EDT 

Tbg Diagnostics Ltd : Entered into exclusive licensing agreement with National Taiwan University Hospital for development & distribution of patented product . TBG Medigen partnership will obtain worldwide exclusive right to develop and distribute an invitro diagnostic (IVD) product .Agreement in association with Taiwan based biopharmaceutical company Medigen Corp.  Full Article

TBG Diagnostics to acquire controlling equity stake in RBC Biosciences
Tuesday, 28 Jun 2016 08:12pm EDT 

TBG Diagnostics Ltd : TBG to acquire controlling equity stake in RBC Biosciences . TBG to acquire 51% of RBC Biosciences for NT$127 million . Addition of RBC is expected to double TBG's annual sales revenues to $A8.1 million .  Full Article

TBG Diagnostics (Previously Progen Pharmaceuticals) announces sale of Pharmasynth Pty Ltd
Thursday, 3 Mar 2016 05:15pm EST 

TBG Diagnostics Ltd (previously Progen Pharmaceuticals):Sale of Pharmasynth Pty Ltd.Deal for total consideration of A$2.2 million.Entered into a binding share sale agreement (ssa) to sell Pharmasynth Pty Ltd to Luina Biotechnology Pty Ltd.  Full Article

Progen Pharmaceuticals raises $12.72 mln under offer
Friday, 11 Dec 2015 05:06am EST 

Progen Pharmaceuticals Ltd:Says Progen successfully raises $12.72 million under offer.Capital raised under the offer exceeds minimum raise target of $10 million.  Full Article

No consensus analysis data available.